The SLC16A11 gene helps liver cells move certain small molecules involved in how the body uses and stores energy. What this gene does can influence how your body handles fats and sugar. Some variants in the SLC16A11 gene may shift this balance, which can lead to more fat buildup in the liver and a higher chance of type 2 diabetes. This link has been studied most in people with Native American ancestry and in many Latin American populations.
What is a gene?
Genes are sections of DNA that hold instructions your cells use to make molecules or manage processes in the body. Some genes provide the information needed to make proteins, the parts of cells that do the work. Other genes mainly guide when certain processes happen, where they happen, and how strongly they operate. As a group, genes affect how the body develops and works, and they can influence how you respond to food, stress, and medications. To explore this topic further, you can find more in the LearnHub.
Overview
SLC16A11Gene function
What if the gene works
The SLC16A11 gene helps liver cells move certain small molecules across membranes. This supports how the body handles fats and energy.
Risk
What if the gene does not work
Some variants in the SLC16A11 gene can alter how liver cells move and process certain fats, which is linked to a higher chance of type 2 diabetes. Milder variants may have smaller effects, while more disruptive variants can have stronger effects.
Treatment
What does that mean for your treatment
No SLC16A11-specific treatment or drug choice is currently established in clinical guidelines. The SLC16A11 gene is being studied as a marker of type 2 diabetes biology, especially how the liver handles certain fats, but this has not changed routine treatment.
Gene function
What if the gene works
Your cells need a steady flow of small molecules to manage energy and fats. The SLC16A11 gene belongs to a family of genes that help move these molecules across membranes. This work is especially relevant in the liver, where much of the body’s metabolic processing takes place.
The SLC16A11 gene makes a transport protein that sits in cell membranes and moves certain small fuel molecules from one side to the other. This steady traffic helps cells manage the materials used in everyday metabolism.
In liver cells, this movement supports how the body handles and stores fats. This is part of how the SLC16A11 gene works in liver cells during normal fat handling.
By helping these molecules cross membranes at the right time, the SLC16A11 gene supports steady day to day chemistry inside cells. This helps routine energy use stay organized.
What is a variant?
A genetic variant is a minor alteration in the DNA sequence within a gene. These changes are common and are part of normal human diversity, including differences in appearance, metabolism, and the way the body responds to environmental influences. Many variants do not have any noticeable effect and simply represent natural genetic variation. In some situations, though, a variant may change how a gene works more significantly and can contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
To understand how variants influence the SLC16A11 gene's function, it helps to know that some DNA changes alter the transport protein’s shape, stability, or ability to reach the cell membrane. This can weaken transport activity or disrupt interactions with partner proteins inside the cell. Milder variants may partly reduce protein function, while more severe variants can markedly impair trafficking or leave very little functional protein.
How variants are linked to conditions
Variants in the SLC16A11 gene are linked to a higher risk of type 2 diabetes, especially in many people with Mexican and other Latin American backgrounds. The SLC16A11 gene and type 2 diabetes risk association is well supported in population studies. These are risk-linked variants, not a diagnosis on their own, so many people who carry them never develop diabetes.
A variant is not necessarily a diagnosis
Variants in genes are a routine part of human biology and are widely found in the general population. Most do not directly affect health and simply contribute to normal human diversity. For many genes, carrying a variant associated with a condition suggests a possible link rather than a certain diagnosis, especially when several genes and environmental factors are involved. In some cases, though, a single well-characterized variant in a particular gene is enough to confirm a diagnosis.
Are there things that can increase or change my risk?
For SLC16A11, the clearest link is a higher chance of type 2 diabetes, and that risk can be further shaped by body weight, physical activity, diet, age, and family history. Having a SLC16A11 change does not mean diabetes is certain, but carrying it alongside other risk factors can raise the chance more.
Inheritance of SLC16A11 variants
For most people, SLC16A11 gene variants are discussed as risk factors for type 2 diabetes rather than as a single-gene condition with a clearly established Mendelian inheritance pattern. In other words, the SLC16A11 inheritance pattern is not defined as autosomal dominant or autosomal recessive for a specific disease in routine clinical genetics. The SLC16A11 gene is located on chromosome 17, which is an autosome, so you inherit one copy from each parent.
What does my SLC16A11 result mean for my family?
There is not a broadly confirmed single-gene inheritance pattern for SLC16A11 tied to a specific inherited condition. Changes in the SLC16A11 gene are better understood as one factor that can raise the chance of type 2 diabetes, alongside many other genes, family history, weight, diet, activity, and other health factors, so a result does not by itself show what relatives will or will not develop.
Genetic information
Genetic testing
How you find out about variants
A blood or saliva test can check for variants in the SLC16A11 gene. In genetic testing for SLC16A11 variants, a lab reads your DNA and compares it with the usual sequence. Results can show whether you carry a variant linked to type 2 diabetes risk, but they do not diagnose diabetes on their own.
When should I consider getting a genetic test?
There isn't yet a broadly established, SLC16A11-specific clinical reason for testing. Changes in this gene are linked with type 2 diabetes risk in some groups, but they do not diagnose diabetes or usually change care, so testing decisions are best made with a doctor or genetic counselor based on your own and family history.
A genetic result is only one part of your health story
Genetic results can provide useful insight, but how much they reveal depends on the condition and on the type of variant involved. Over time, many factors, including lifestyle, environment, age, and medical history, influence how the body functions. For some conditions, especially those shaped by many genes, genetic information offers context rather than certainty and is most useful when viewed alongside other parts of care. In other situations, a genetic result may give a clear answer. In areas like medication response, genetic results can also help make sense of individual experiences.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. Small differences in DNA can change how the body absorbs, breaks down, moves, or responds to a drug, so the same treatment may work better for one person than for another. These differences are common and can influence both how much benefit someone gets and how sensitive they may be to side effects.
What is Pharmacogenetics?
Pharmacogenetics is the area of study that examines how genetic differences affect the way people respond to medications. It focuses on gene and drug patterns to better explain why treatments can work differently from one person to another. For many medicines, genes influence both how strongly a drug works and how the body handles it. This information can support more informed and more individualized treatment decisions. More on this topic is available in the LearnHub.
Drugs influenced by the SLC16A11 gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in guiding how medicines are chosen or used, so general questions about treatment are best discussed with your doctor. Medical advice is especially important if you have side effects, your blood sugar is harder to control, or you are thinking about changing a diabetes medicine.
History
The SLC16A11 gene entered medical research more recently than many well known genes, after large genetic studies looked for reasons type 2 diabetes risk differs across populations. In recent decades, awareness of this gene’s role has grown as researchers found a variant pattern in SLC16A11 that is more common in people with Native American ancestry and many Latin American populations. This drew attention because it helped explain part of the inherited risk seen in Mexico and other regions, while also highlighting how genetics research had long underrepresented these communities. A major milestone came in 2014, when an international study linked the SLC16A11 gene to type 2 diabetes. Soon after, researchers reported that this risk linked version was likely inherited from Neanderthals, adding an unexpected chapter to its story.